GH
ICPT

GAM Holding’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

GAM Holding’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-15,600
Closed -$2.23M – 983
2016
Q2 		$2.23M Sell
15,600
-1,900
-11% -$277K 0.03% 490
2016
Q1 		$2.25M Hold
17,500
– – 0.04% 447
2015
Q4 		$2.61M Hold
17,500
– – 0.04% 430
2015
Q3 		$2.9M Buy
17,500
+5,300
+43% +$1.17M 0.05% 379
2015
Q2 		$2.94M Buy
12,200
+1,700
+16% +$453K 0.04% 420
2015
Q1 		$2.96M Sell
10,500
-1,500
-13% -$325K 0.04% 409
2014
Q4 		$1.87M Hold
12,000
– – 0.03% 523
2014
Q3 		$2.84M Buy
12,000
+6,000
+100% +$1.53M 0.04% 412
2014
Q2 		$1.42M Buy
+6,000
New +$1.58M 0.02% 614

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAM Holding's ICPT Position: Q3 2016 in Review

GAM Holding sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2016, closing a stake of 15,600 shares — an estimated $2.23M sold.

GAM Holding first reported a position in ICPT in Q2 2014 and held it in 9 quarters. The position peaked at $2.96M in Q1 2015. 172 funds tracked by Wall St. Rank hold ICPT as of Q3 2016.

  • GAM Holding reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • GAM Holding sold 15,600 Intercept Pharmaceuticals, Inc. shares in Q3 2016, an estimated $2.23M.
  • GAM Holding first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 9 quarters.
  • GAM Holding's Intercept Pharmaceuticals, Inc. position peaked at $2.96M in Q1 2015.
  • 172 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2016.

Based on GAM Holding's 13F filing for Q3 2016, filed 7 Nov 2016.